tag:blogger.com,1999:blog-28089527.post-11318425821374250332008-05-02T12:50:00.000+01:002008-05-02T12:50:00.000+01:002008-05-02T12:50:00.000+01:00Simvastatin is cheap and will get about 50 - 60% of patients to the current target - though that is about to be lowered to 4 & 2 by NICE. Upping the dose of Simvastatin above 40 only increases the chance of side effects. I use Rosuvastatin second line, even cheaper than Atorvastatin but more effective. The PharmaNazis have red-listed it here but fuck 'em. When did a pharmacist last treat a patient, eh?Anonymousnoreply@blogger.com